MX2016016079A - Sistema de hidroalcoholico para el tratamiento de las uñas. - Google Patents

Sistema de hidroalcoholico para el tratamiento de las uñas.

Info

Publication number
MX2016016079A
MX2016016079A MX2016016079A MX2016016079A MX2016016079A MX 2016016079 A MX2016016079 A MX 2016016079A MX 2016016079 A MX2016016079 A MX 2016016079A MX 2016016079 A MX2016016079 A MX 2016016079A MX 2016016079 A MX2016016079 A MX 2016016079A
Authority
MX
Mexico
Prior art keywords
nail treatment
mixtures
hydroalcoholic system
hydroalcoholic
poloxamer
Prior art date
Application number
MX2016016079A
Other languages
English (en)
Inventor
J Otero Espinar Francisco
Soledad F Anguiano Igea M
Elena CUTRÍN GÓMEZ M
Luis Gómez Amoza José
Original Assignee
Univ Santiago Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Santiago Compostela filed Critical Univ Santiago Compostela
Publication of MX2016016079A publication Critical patent/MX2016016079A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica que comprende (i) poloxámero 407, (ii) al menos un potenciador de la penetración, (iii) al menos un agente solubilizante seleccionado del grupo que consiste en ciclodextrinas, polímeros hidrófilos y mezclas de los mismos, (iv) al menos una sustancia biológicamente activa y (v) un vehículo que comprende agua y un alcohol C1-C3, o mezclas de los mismos.
MX2016016079A 2014-06-04 2015-06-03 Sistema de hidroalcoholico para el tratamiento de las uñas. MX2016016079A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382215.3A EP2952208A1 (en) 2014-06-04 2014-06-04 Hydroalcoholic system for nail treatment
PCT/EP2015/062413 WO2015185647A1 (en) 2014-06-04 2015-06-03 Hydroalcoholic system for nail treatment

Publications (1)

Publication Number Publication Date
MX2016016079A true MX2016016079A (es) 2017-07-28

Family

ID=50942639

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016016079A MX2016016079A (es) 2014-06-04 2015-06-03 Sistema de hidroalcoholico para el tratamiento de las uñas.

Country Status (17)

Country Link
US (1) US20170224669A1 (es)
EP (2) EP2952208A1 (es)
JP (1) JP6742920B2 (es)
KR (1) KR102394176B1 (es)
CN (1) CN106456781B (es)
AU (1) AU2015270537B2 (es)
BR (1) BR112016028412B1 (es)
CA (1) CA2950478C (es)
ES (1) ES2831973T3 (es)
HU (1) HUE051352T2 (es)
LT (1) LT3151863T (es)
MX (1) MX2016016079A (es)
PL (1) PL3151863T3 (es)
PT (1) PT3151863T (es)
RU (1) RU2730010C2 (es)
SI (1) SI3151863T1 (es)
WO (1) WO2015185647A1 (es)

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3162081D1 (en) 1980-04-29 1984-03-08 Lucas Ind Plc Brake master cylinder
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
DE4212105A1 (de) 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
US5464610A (en) 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
FR2705563B1 (fr) 1993-05-26 1995-07-07 Oreal Vernis à ongles aqueux, incolore ou coloré, contenant un polymère filmogène à l'état dispersé et un composé perfluoroalkyle hydrosoluble.
US5391367A (en) 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution
FR2711059B1 (fr) 1993-10-15 1996-02-02 Oreal Composition cosmétique sous forme de vernis à ongles aqueux, coloré ou incolore, contenant en tant que substance filmogène des particules de polyester-polyuréthanne anionique à l'état dispersé.
JPH07223942A (ja) * 1994-02-03 1995-08-22 Ildong Pharm Co Ltd プロピオン酸系非ステロイド性薬物を有効成分として含有する新規消炎鎮痛外用ゲル製剤
US5487776A (en) 1994-03-17 1996-01-30 Nimni; Marcel Anti-fungal nail lacquer and method therefor
US5696164A (en) 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US5696105A (en) 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
KR100220403B1 (ko) * 1997-03-25 1999-09-15 박성원 각질 투과 증가제를 기제성분으로 함유하는 항진균성 손.발톱 와니스
US6224887B1 (en) 1998-02-09 2001-05-01 Macrochem Corporation Antifungal nail lacquer and method using same
FR2775593B1 (fr) 1998-03-09 2002-06-14 Oreal Composition filmogene comprenant un polyurethane en dispersion aqueuse et un agent plastifiant
US6159977A (en) 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
US6495124B1 (en) 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
US20030049320A1 (en) * 2000-12-18 2003-03-13 Wockhardt Limited Novel in-situ forming controlled release microcarrier delivery system
US6881726B2 (en) * 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
PL2106805T3 (pl) * 2003-03-21 2011-10-31 Nexmed Holdings Inc Przeciwgrzybicza powłoka na paznokcie
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
RU2238722C1 (ru) * 2003-06-25 2004-10-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция с обезболивающим и противовоспалительным действием
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
EP1970076A4 (en) 2005-12-28 2012-12-12 Teikoku Seiyaku Kk PHARMACEUTICAL COMPOSITION FOR APPLYING TO A NAIL
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
GB0720716D0 (en) * 2007-10-23 2007-12-05 York Pharma Plc Novel formulation
US20090175810A1 (en) * 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US20090175945A1 (en) 2008-01-08 2009-07-09 Jie Zhang Systems, Methods, and Formulations for Topically Treating Nail Fungal Infections and Nail Psoriasis
CA2712120A1 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
AU2010336441B2 (en) * 2009-12-23 2015-02-05 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis
ES2369101B2 (es) * 2010-05-07 2012-08-02 Universidade De Santiago De Compostela Sistema farmacéutico acuoso para la administración de fármacos en las uñas.
JP2012017318A (ja) * 2010-06-07 2012-01-26 Nikko Chemical Co Ltd 液晶及びそれを含有する皮膚外用剤

Also Published As

Publication number Publication date
PL3151863T3 (pl) 2021-03-08
AU2015270537B2 (en) 2019-12-05
ES2831973T3 (es) 2021-06-09
AU2015270537A1 (en) 2016-12-15
CN106456781B (zh) 2020-07-10
LT3151863T (lt) 2021-08-10
RU2016147020A (ru) 2018-05-30
JP2017523135A (ja) 2017-08-17
RU2016147020A3 (es) 2018-12-26
EP3151863A1 (en) 2017-04-12
EP3151863B1 (en) 2020-08-12
KR20170008763A (ko) 2017-01-24
RU2730010C2 (ru) 2020-08-14
BR112016028412A2 (pt) 2017-08-22
CA2950478C (en) 2022-04-12
WO2015185647A1 (en) 2015-12-10
EP2952208A1 (en) 2015-12-09
SI3151863T1 (sl) 2021-03-31
BR112016028412B1 (pt) 2023-05-02
HUE051352T2 (hu) 2021-03-01
KR102394176B1 (ko) 2022-05-03
US20170224669A1 (en) 2017-08-10
PT3151863T (pt) 2020-11-19
CN106456781A (zh) 2017-02-22
CA2950478A1 (en) 2015-12-10
JP6742920B2 (ja) 2020-08-19

Similar Documents

Publication Publication Date Title
IL284913A (en) A multispecific antigen-binding molecule that has the function-changing activity of a cofactor for blood coagulation factor viii (fviii), and a pharmaceutical formulation containing the molecule as an active ingredient
EA201790174A1 (ru) Антипролиферативные соединения и способы их применения
CY1124380T1 (el) Συστηματα διαβλεννογονιας και διαδερμικης χορηγησης
EP4349997A3 (en) Anti-garp antibody
SA518400356B1 (ar) مثبطات الأرجيناز واستخداماتها العلاجية
MY187047A (en) Selective pyy compounds and uses thereof
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
CL2016002072A1 (es) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
MX2022014634A (es) Metodos para la administracion linfatica de agentes activos.
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
EP4218823A3 (en) Novel polymeric hgh prodrugs
CL2019001329A1 (es) Composiciones farmacéuticas moduladoras del receptor 7 de 5-hidroxitritpina y métodos de uso.
PH12017500436A1 (en) Novel pharmaceutical composition for prevention and/or treatment of urinary incontinence
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
BR112017028468A2 (pt) formulação sólida oral, e método para preparar uma formulação sólida oral
MX2023006235A (es) Composiciones para administracion de farmacos y metodos de uso de las mismas.
EP3835311C0 (en) NKX3.2 FRAGMENT AND PHARMACEUTICAL COMPOSITION COMPRISING IT AS ACTIVE INGREDIENT
PH12016501733A1 (en) Pharmaceutical composition for preventing or treating skin rash
WO2015001541A3 (en) Pharmaceutical film composition
MX2016016079A (es) Sistema de hidroalcoholico para el tratamiento de las uñas.
EP3881845A3 (en) Combination of trazodone and gabapentin for the treatment of pain
CL2020003153A1 (es) Composiciones antimicrobianas con agentes efervescentes (divisional de solicitud n° 03273-2016)
WO2018094035A3 (en) Ligand ionophore conjugates
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза
SA519401755B1 (ar) صيغ مضادة للمكروبات لعلاج عدوى الحوافر البيطرية

Legal Events

Date Code Title Description
FG Grant or registration